|
Monday, 17 October 2011 00:44 |
 Skanska (STO:SKAB) has signed a contract with Merck (NYSE:MRK), known outside of the United States and Canada as MSD, to complete the renovation of a research and development laboratory at Merck's facility in Kenilworth, New Jersey.
|
|
Read more...
|
|
Monday, 17 October 2011 00:00 |
 MediciNova Inc., a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasdaq:MNOV - News) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced that Kissei Pharmaceutical Co. Ltd., a pharmaceutical company traded on the Tokyo Stock Exchange (4547), will pay MediciNova $2.5 million, within 30 days, to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD).
|
|
Read more...
|
|
Saturday, 15 October 2011 00:45 |
|
Cleave Biosciences, a newly established biopharmaceutical company discovering and developing novel therapies for cancer, announced today it has raised $42 million in Series A financing. Cleave Biosciences was established by Scientific Co-Founders Raymond Deshaies, Ph.D., Seth Cohen, Ph.D. and Francesco Parlati, Ph.D.
|
|
Read more...
|
|
Friday, 14 October 2011 00:29 |
 DNAnexus, a DNA data management and analysis platform, today announced that it has secured $15 million in second-round funding, led by Google Ventures and TPG Biotech. Additional participants in this round of financing include institutional investors First Round Capital, SoftTech VC, K9 Ventures, and Felicis Ventures.
|
|
Read more...
|
|
Thursday, 13 October 2011 00:43 |
 Accudial Pharmaceutical®, Inc. has acquired Stephen Key Design, LLC. This acquisition expands AccuDial's patent portfolio to over fifty patents for weight based dosing and other extended content rotating labels (ECRL), which adds 75% more labeling space to a container.
|
|
Read more...
|
|
Wednesday, 12 October 2011 00:35 |
 The construction of Liverpool Science Park (LSP)’s third building will commence on site next year following the announcement of a £7.6M funding package.
|
|
Read more...
|
|
Wednesday, 12 October 2011 00:29 |
 United Therapeutics Corporation (NASDAQ: UTHR) announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform. Based on the support from this contract, approximately 20 jobs will be created at Unither Virology's headquarters in Silver Spring, Maryland, with additional jobs created at subcontractor organizations.
|
|
Read more...
|
|
Tuesday, 11 October 2011 00:03 |
 American Oriental Bioengineering, Inc. (NYSE: AOB), or (the "Company") today announced that the Company submitted its plan to cure stock price deficiency with respect to the listing standard of the New York Stock Exchange ("NYSE") on October 5, 2011.
|
|
Read more...
|
|
Monday, 10 October 2011 00:57 |
 Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, November 1, 2011, to discuss third quarter 2011 results followed by a Q&A session. The company will release earnings the same day before the market opens.
|
|
|
|
Read more...
|
|
Monday, 10 October 2011 00:50 |
|
 CEL-SCI Corporation (NYSE AMEX: CVM) announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation’s common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.
|
|
Read more...
|
|
|
Monday, 17 October 2011 00:38 |
 Depomed, Inc. /quotes/zigman/63635/quotes/nls/depo DEPO -25.96% today announced top-line results from BREEZE 3, a Phase 3 trial evaluating the efficacy and safety of Serada(R) (extended-release gabapentin tablets) for menopausal hot flashes.
|
|
Read more...
|
|
Saturday, 15 October 2011 00:47 |
 GlycoMimetics, Inc. announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. (NYSE:PFE - News) for the GlycoMimetics investigational compound GMI-1070.
|
|
Read more...
|
|
Saturday, 15 October 2011 00:42 |
|
 Courtagen Life Sciences - formerly Avantra Biosciences - has completed an $8 million offering, raising the amount from 67 investors.
The capital adds to a $7 million round completed last year.
|
|
Read more...
|
|
Friday, 14 October 2011 00:27 |
|
 Baxter International Inc. (BAX), the maker of blood products and intravenous drugs, declined 3.1 percent after an analyst said the company may be hurt by health insurer Aetna Inc. (AET)’s decision to favor a rival Grifols SA (GRF) treatment for immune system disorders.
|
|
Read more...
|
|
Thursday, 13 October 2011 00:40 |
 ICF International (NASDAQ:ICFI - News), a leading provider of consulting services and technology solutions to government and commercial clients, has won a re-compete contract with the Centers for Disease Control and Prevention (CDC) to provide data management support and technical assistance to more than 40 CDC-funded grantees. The contract has a value of $9.7 million and a term of one base year and four option years.
|
|
Read more...
|
|
Wednesday, 12 October 2011 00:33 |
|
AstraZeneca will spend $200 million to build a major new manufacturing facility in Taizhou’s China Medical City. The plant, which will produce both IV and solid oral medications for the China market, is the largest investment AstraZeneca has ever made in a single manufacturing site.
|
|
Read more...
|
|
Tuesday, 11 October 2011 00:06 |
 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its third quarter 2011 financial results on Thursday, October 27, 2011 after the financial markets close. The company will host a conference call at 5:00 p.m. EDT.
|
|
Read more...
|
|
Tuesday, 11 October 2011 00:02 |
|
Square 1 Bank, the exclusive banking partner to entrepreneurs and the venture capital community, is pleased to partner with CoDa Therapeutics, Inc. in providing a $6 million term loan. This financing comes on the heels of a recent $19 million fundraising that the company closed in April.
|
|
Read more...
|
|
Monday, 10 October 2011 00:55 |
 Metabolic Solutions Development Company, LLC (MSDC) announced today it has received a $1.1 million multi-year Small Business Technology Transfer Program (STTR) grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH).
|
|
Read more...
|
|
Saturday, 08 October 2011 01:05 |
 Illumina, Inc. (NASDAQ:ILMN) today announced estimated third quarter revenue of approximately $235 million. This estimate is based on management's preliminary financial review and remains subject to review by our independent registered public accounting firm.
|
|
Read more...
|
|
